Nintedanib Plus Docetaxel in Japanese Patients With Adenocarcinoma Subtype Non-small Cell Lung Cancer After Failure of First Line Chemotherapy
Clinical trial NCT02300298 · COMPLETED
Trial details
- NCT number
- NCT02300298
- Sponsor
- Boehringer Ingelheim
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2014-12-24
- Primary completion
- 2016-01-15
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.